Back

Heparin monitoring in ImpellaTM-supported cardiogenic shock patients: the benefit of parallel dual testing

8 March 2024 (13:29 - 13:41)
Organised by: Logo
Congress Presentation Part of: Young Investigator Awards Cardiac Care Unit (CCU), Intensive, and Critical Cardiovascular Care ACVC Premium Access ESC Acute CardioVascular Care 2024 Association for Acute CardioVascular Care (ACVC)

About the speaker

Photo
Doctor Charlotte Van Edom

KU Leuven, Leuven (Belgium)

3 More presentations in this session

Presentation thumbnail
Modulation of cytokine response in post-cardiac arrest syndrome through prehospital high-dose glucocorticoid treatment
Doctor L. Obling (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
All lactate are not equal substudy of the BOX trial
Doctor R. Paulin Beske (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
SCAI SHOCK stage classification: valid for all indications and devices in patients with short-term mechanical circulatory support?
Doctor A. Hernandez Martos (Barcelona, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Young Investigator Awards

The Event

Event poster

ESC Acute CardioVascular Care 2024

8 March 2024 13:29 CET
You may be interested in
thumbnail
Congress Presentation
Dual guided heparin monitoring with anti-Xa and APTT during micro-axial flow pump support for cardiogenic shock
thumbnail
Congress Presentation
How to personalise antithrombotic treatment in the patient on mechanical circulatory support
thumbnail
Congress Presentation
What is the optimal antithrombotic treatment?

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources